Individualized Lyme Disease Treatment: Why It Matters
Individualized Lyme disease treatment may improve long-term recovery.
Persistent symptoms can reflect coinfections, neurologic involvement, or delayed care.
Early recognition and proactive treatment decisions may reduce chronic illness risk.
Proactive individualized Lyme treatment can be the difference between full recovery and chronic illness.
In my practice, I’ve seen patients respond very differently depending on how—and how soon—their Lyme disease was treated. Some improve after a brief course of antibiotics. Others continue to struggle for months or years, often because their care was too limited, too delayed, or not tailored to their full symptom picture.
That’s why I make the case for a more proactive, individualized Lyme disease treatment strategy—one that responds to each patient’s unique history, risk factors, and evolving symptoms.
Three common Lyme disease treatment strategies
Let’s look at the three treatment strategies I encounter most often in clinical practice and why the differences matter.
1. Short-course antibiotic protocol
The short-course approach—typically 21 to 28 days of doxycycline—is the default for many clinicians. It is recommended in CDC guidance and may work well for some patients, particularly when Lyme disease is recognized early and symptoms are mild.
But it is not always enough.
Many of my patients seek additional care after short-course treatment because symptoms continue.
- Severe fatigue
- Brain fog
- Joint and muscle pain
- Dizziness or palpitations
- Night sweats and insomnia
Too often, these symptoms are attributed to post-treatment Lyme disease syndrome (PTLDS) without investigating further.
In some patients, persistent symptoms may reflect ongoing infection, neurologic involvement, autonomic dysfunction, or missed coinfections rather than residual inflammation alone.
For related recovery pathways, see post-treatment Lyme disease syndrome.
2. Watchful waiting approach
In this strategy, treatment is withheld or stopped despite unresolved symptoms. Patients are told to “wait and see” whether recovery occurs naturally over time.
This may be reasonable in mild or self-limited situations. However, in other patients, delayed reassessment may allow symptoms to worsen.
The problem is that watchful waiting assumes the infection has cleared.
But what if it has not?
What if the symptoms reflect Babesia, Bartonella, autonomic dysfunction, neuroinflammation, or persistent Borrelia-related illness?
By the time some patients return for reevaluation, they may already have developed:
- Neurologic Lyme disease
- Dysautonomia or POTS
- Neuropsychiatric symptoms
- Cognitive impairment
In some cases, earlier intervention may have reduced long-term complications.
3. Proactive individualized Lyme disease treatment
This is the treatment approach I rely on most in my clinical practice.
It means listening carefully to the patient’s symptoms, recognizing patterns of coinfection or treatment failure, and making timely decisions even when laboratory testing remains inconclusive.
A proactive individualized Lyme disease treatment strategy may involve:
- Extending antibiotic treatment when symptoms clearly persist
- Using combination therapy for different forms of Borrelia
- Treating Babesia when night sweats or air hunger are present
- Evaluating Bartonella when psychiatric, neurologic, or vascular symptoms emerge
- Supporting autonomic dysfunction when POTS or orthostatic intolerance develops
This is not simply “more treatment.” It is symptom-driven, individualized care that adapts to the complexity of tick-borne illness.
A patient who did not wait
One of my patients, a 42-year-old professional, came to me after a confirmed tick bite and a three-week course of doxycycline.
Initially, her symptoms improved. But within weeks, they returned.
- Debilitating fatigue
- Sharp knee and wrist pain
- Brain fog severe enough that she forgot her phone number
- Resting heart rate above 100 beats per minute with minimal activity
Her previous physician believed this represented “post-Lyme inflammation” and advised additional time and rest.
However, her symptoms suggested both Lyme disease and Babesia despite negative Babesia laboratory testing.
Because of her history of night sweats and breathlessness at rest, I added atovaquone and azithromycin while continuing Lyme-directed treatment.
Three months later, she had returned to work, resumed exercise, and described feeling “like herself again for the first time in over a year.”
Her recovery did not come from waiting longer. It came from individualized treatment that addressed both Lyme disease and a likely missed coinfection.
Why individualized Lyme disease treatment matters
Lyme disease rarely behaves like a single uniform illness.
One patient may develop arthritis while another experiences heart block, dysautonomia, panic attacks, neuropathy, or cognitive dysfunction.
Coinfections often go unrecognized, and standard laboratory testing may miss important clinical clues.
That is why clinical judgment remains essential.
When evaluating patients, I consider:
- Timing and nature of tick exposure
- Presence of night sweats, dizziness, or cognitive symptoms
- Partial or temporary responses to antibiotics
- Risk factors for coinfections
- Autonomic or neurologic symptoms
In short, I treat the patient—not just the protocol.
Frequently Asked Questions
Can Lyme disease symptoms persist after antibiotics?
Yes. Some patients continue experiencing fatigue, pain, cognitive symptoms, dysautonomia, or neurologic problems after initial Lyme disease treatment.
What if Lyme disease symptoms return after treatment?
Recurring symptoms may warrant reevaluation for coinfections, persistent inflammation, autonomic dysfunction, neurologic involvement, or incomplete response to therapy.
Can Babesia or Bartonella affect Lyme disease recovery?
Yes. Coinfections such as Babesia and Bartonella may complicate recovery and contribute to persistent symptoms.
Why is individualized Lyme disease treatment important?
Patients present differently, respond differently to treatment, and may have overlapping infections or complications that require individualized clinical decisions.
Can Lyme disease cause brain fog even after treatment?
Yes. Brain fog, memory problems, slowed processing, and concentration difficulties may persist in some patients despite initial treatment.
Clinical Takeaway
Individualized Lyme disease treatment recognizes that patients do not all follow the same clinical pathway.
Persistent symptoms after treatment may reflect coinfections, neurologic complications, autonomic dysfunction, inflammatory responses, or delayed diagnosis.
Early symptom recognition and proactive individualized treatment decisions may improve long-term recovery and reduce progression to chronic illness.
Related Articles
These related articles explore persistent symptoms, coinfections, treatment decisions, and recovery pathways associated with Lyme disease.
Neurologic Lyme disease
Persistent Lyme disease
Lyme coinfections
Autonomic dysfunction in Lyme disease
Lyme disease brain fog
References
- Cameron DJ, Johnson LB, Maloney EL. Evidence assessments and guideline recommendations in Lyme disease: The clinical management of known tick bites, erythema migrans rashes and persistent disease. Expert Rev Anti Infect Ther. 2014;12(9):1103-1135.
- CDC – Lyme Disease Treatment. Centers for Disease Control and Prevention. Accessed 2026.
- Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43(9):1089-1134.
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
